These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31646100)

  • 1. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
    Kaffes I; Szulzewsky F; Chen Z; Herting CJ; Gabanic B; Velázquez Vega JE; Shelton J; Switchenko JM; Ross JL; McSwain LF; Huse JT; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L; Maturi NP; Cimino PJ; Holland EC; Kettenmann H; Brennan CW; Brat DJ; Hambardzumyan D
    Oncoimmunology; 2019; 8(11):e1655360. PubMed ID: 31646100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune landscapes associated with different glioblastoma molecular subtypes.
    Martinez-Lage M; Lynch TM; Bi Y; Cocito C; Way GP; Pal S; Haller J; Yan RE; Ziober A; Nguyen A; Kandpal M; O'Rourke DM; Greenfield JP; Greene CS; Davuluri RV; Dahmane N
    Acta Neuropathol Commun; 2019 Nov; 7(1):203. PubMed ID: 31815646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
    Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR
    Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
    Engler JR; Robinson AE; Smirnov I; Hodgson JG; Berger MS; Gupta N; James CD; Molinaro A; Phillips JJ
    PLoS One; 2012; 7(8):e43339. PubMed ID: 22937035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage.
    Cui X; Wang Q; Zhou J; Wang Y; Xu C; Tong F; Wang H; Kang C
    Front Oncol; 2021; 11():710695. PubMed ID: 34434898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies.
    Morisse MC; Jouannet S; Dominguez-Villar M; Sanson M; Idbaih A
    Expert Rev Neurother; 2018 Sep; 18(9):729-737. PubMed ID: 30099909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
    Li H; He J; Li M; Li K; Pu X; Guo Y
    Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
    Li M; Xiao A; Floyd D; Olmez I; Lee J; Godlewski J; Bronisz A; Bhat KPL; Sulman EP; Nakano I; Purow B
    Oncotarget; 2017 Aug; 8(33):55319-55331. PubMed ID: 28903422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
    Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
    Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Transcriptomics Revealed Subtype-Specific Tumor Immune Microenvironments in Human Glioblastomas.
    Xiao Y; Wang Z; Zhao M; Deng Y; Yang M; Su G; Yang K; Qian C; Hu X; Liu Y; Geng L; Xiao Y; Zou Y; Tang X; Liu H; Xiao H; Fan R
    Front Immunol; 2022; 13():914236. PubMed ID: 35669791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
    Wang Q; Hu B; Hu X; Kim H; Squatrito M; Scarpace L; deCarvalho AC; Lyu S; Li P; Li Y; Barthel F; Cho HJ; Lin YH; Satani N; Martinez-Ledesma E; Zheng S; Chang E; Sauvé CG; Olar A; Lan ZD; Finocchiaro G; Phillips JJ; Berger MS; Gabrusiewicz KR; Wang G; Eskilsson E; Hu J; Mikkelsen T; DePinho RA; Muller F; Heimberger AB; Sulman EP; Nam DH; Verhaak RGW
    Cancer Cell; 2017 Jul; 32(1):42-56.e6. PubMed ID: 28697342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.
    Qi T; Meng X; Wang Z; Wang X; Sun N; Ming J; Ren L; Jiang C; Cai J
    Front Oncol; 2021; 11():595259. PubMed ID: 33816228
    [No Abstract]   [Full Text] [Related]  

  • 18. ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma.
    Lailler C; Louandre C; Morisse MC; Lhossein T; Godin C; Lottin M; Constans JM; Chauffert B; Galmiche A; Saidak Z
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.